Download PDF
Semin Reprod Med 2013; 31(04): 286-292
DOI: 10.1055/s-0033-1345276
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Avoiding Toxins Including Spermatotoxic Medications

Gillian Stearns
1   Department of Urology, SUNY Upstate Medical University, Syracuse, New York
,
Paul J. Turek
2   The Turek Clinic, San Francisco, California
› Author Affiliations
Further Information

Publication History

Publication Date:
17 June 2013 (online)

    Permissions and Reprints

Abstract

Global rates of infertility are significant, especially in many developing countries. In developed countries, infertility affects up to 15% of the reproductive-age population, with male factors involved in 50% of cases. During medical evaluation, a review of current and past medications and social habits is essential, as they may adversely affect fertility. In addition, knowledge of exposure is important for counseling regarding future fertility, as many such toxic exposures have reversible effects. We reviewed the English literature over the past 35 years for all types of studies that have examined drug, medication, and other exposures that have been linked to altered semen quality and male fertility. Both human and animal studies were included in this analysis. The goal of this review is to delineate the medication and habitual risk factors that have been associated with male infertility.

Keywords

male infertility - medications - semen analysis - azoospermia - toxicology
 

  • References

  • 1 Pasqualotto FF, Lucon AM, Sobreiro BP, Pasqualotto EB, Arap S. Effects of medical therapy, alcohol, smoking, and endocrine disruptors on male infertility. Rev Hosp Clin Fac Med Sao Paulo 2004; 59 (6) 375-382
    PubMedGoogle Scholar
  • 2 Turek PJ. Practical approach to the diagnosis and management of male infertility. Nat Clin Pract Urol 2005; 2: 1-13
    PubMedGoogle Scholar
  • 3 Nudell DM, Monoski MM, Lipshultz LI. Common medications and drugs: how they affect male fertility. Urol Clin North Am 2002; 29 (4) 965-973
    CrossrefPubMedGoogle Scholar
  • 4 Natali A, Turek PJ. An assessment of new sperm tests for male infertility. Urology 2011; 77 (5) 1027-1034
    CrossrefPubMedGoogle Scholar
  • 5 Amory JK. Drug effects on spermatogenesis. Drugs Today (Barc) 2007; 43 (10) 717-724
    CrossrefPubMedGoogle Scholar
  • 6 Turek PJ. Does the male infertility clinical evaluation adequately assess toxicologic exposures?. Fertil Steril 2008; 89 (2, Suppl): e69
    CrossrefPubMedGoogle Scholar
  • 7 Künzle R, Mueller MD, Hänggi W, Birkhäuser MH, Drescher H, Bersinger NA. Semen quality of male smokers and nonsmokers in infertile couples. Fertil Steril 2003; 79 (2) 287-291
    CrossrefPubMedGoogle Scholar
  • 8 Ahmadnia H, Ghanbari M, Moradi MR, Khaje-Dalouee M. Effect of cigarette smoke on spermatogenesis in rats. Urol J 2007; 4 (3) 159-163
    PubMedGoogle Scholar
  • 9 Sofikitis N, Miyagawa I, Dimitriadis D, Zavos P, Sikka S, Hellstrom W. Effects of smoking on testicular function, semen quality and sperm fertilizing capacity. J Urol 1995; 154 (3) 1030-1034
    CrossrefPubMedGoogle Scholar
  • 10 Tawadrous GA, Aziz AA, Mostafa T. Effect of smoking status on seminal parameters and apoptotic markers in infertile men. J Urol 2011; 186 (5) 1986-1990
    CrossrefPubMedGoogle Scholar
  • 11 Ramlau-Hansen CH, Thulstrup AM, Aggerholm AS, Jensen MS, Toft G, Bonde JP. Is smoking a risk factor for decreased semen quality? A cross-sectional analysis. Hum Reprod 2007; 22 (1) 188-196
    CrossrefPubMedGoogle Scholar
  • 12 Pasqualotto FF, Sobreiro BP, Hallak J, Pasqualotto EB, Lucon AM. Cigarette smoking is related to a decrease in semen volume in a population of fertile men. BJU Int 2006; 97 (2) 324-326
    CrossrefPubMedGoogle Scholar
  • 13 Künzle R, Mueller MD, Hänggi W, Birkhäuser MH, Drescher H, Bersinger NA. Semen quality of male smokers and nonsmokers in infertile couples. Fertil Steril 2003; 79 (2) 287-291
    CrossrefPubMedGoogle Scholar
  • 14 Saleh RA, Agarwal A, Sharma RK, Nelson DR, Thomas Jr AJ. Effect of cigarette smoking on levels of seminal oxidative stress in infertile men: a prospective study. Fertil Steril 2002; 78 (3) 491-499
    CrossrefPubMedGoogle Scholar
  • 15 Trummer H, Habermann H, Haas J, Pummer K. The impact of cigarette smoking on human semen parameters and hormones. Hum Reprod 2002; 17 (6) 1554-1559
    CrossrefPubMedGoogle Scholar
  • 16 Rossato RM. Endocannabinoids, sperm functions and energy metabolism. Mol Cell Endocrinol 2008; 286: S31-S35
    CrossrefPubMedGoogle Scholar
  • 17 Whan LB, West MCL, McClure N, Lewis SE. Effects of delta-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro. Fertil Steril 2006; 85 (3) 653-660
    CrossrefPubMedGoogle Scholar
  • 18 Buchanan JF, Davis LJ. Drug-induced infertility. Drug Intell Clin Pharm 1984; 18 (2) 122-132
    PubMedGoogle Scholar
  • 19 Mandal TK, Das NS. Testicular toxicity in cannabis extract treated mice: association with oxidative stress and role of antioxidant enzyme systems. Toxicol Ind Health 2010; 26 (1) 11-23
    CrossrefPubMedGoogle Scholar
  • 20 Thonneau P, Bujan L, Multigner L, Mieusset R. Occupational heat exposure and male fertility: a review. Hum Reprod 1998; 13 (8) 2122-2125
    CrossrefPubMedGoogle Scholar
  • 21 Shefi S, Tarapore PE, Walsh TJ, Croughan C, Turek PJ. The reversibility of hyperthermia on semen quality in infertile men. Int Braz J Urol 2007; 33: 50-56 , discussion 56–57
    CrossrefPubMedGoogle Scholar
  • 22 Miyamoto T, Tsujimura A, Miyagawa Y, Koh E, Namiki M, Sengoku K. Male infertility and its causes in human. Adv Urol 2012; 2012: 384520 . doi: 10.1155/2012/384520
    PubMedGoogle Scholar
  • 23 Agarwal A, Singh A, Hamada A , et al. Cell phones and male infertility: a review of recent innovations in technology and consequences. Int Braz J Urol 2001; 37: 432-454
    PubMedGoogle Scholar
  • 24 Avendaño C, Mata A, Sanchez Sarmiento CA, Doncel GF. Use of laptop computers connected to internet through Wi-Fi decreases human sperm motility and increases sperm DNA fragmentation. Fertil Steril 2012; 97 (1) 39-45 , e2
    CrossrefPubMedGoogle Scholar
  • 25 Gutschi T, Mohamad Al-Ali B, Shamloul R, Pummer K, Trummer H. Impact of cell phone use on men's semen parameters. Andrologia 2011; 43 (5) 312-316
    CrossrefPubMedGoogle Scholar
  • 26 Abell A, Ernst E, Bonde JPE. Semen quality and sexual hormones in greenhouse workers. Scand J Work Environ Health 2000; 26 (6) 492-500
    CrossrefPubMedGoogle Scholar
  • 27 Kamijima M, Hibi H, Gotoh M , et al. A survey of semen indices in insecticide sprayers. J Occup Health 2004; 46 (2) 109-118
    CrossrefPubMedGoogle Scholar
  • 28 Larsen SB, Joffe M, Bonde JP. ASCLEPIOS Study Group. Time to pregnancy and exposure to pesticides in Danish farmers. Occup Environ Med 1998; 55 (4) 278-283
    CrossrefPubMedGoogle Scholar
  • 29 Recio-Vega R, Ocampo-Gómez G, Borja-Aburto VH, Moran-Martínez J, Cebrian-Garcia ME. Organophosphorus pesticide exposure decreases sperm quality: association between sperm parameters and urinary pesticide levels. J Appl Toxicol 2008; 28 (5) 674-680
    CrossrefPubMedGoogle Scholar
  • 30 Jurewicz J, Hanke W, Radwan M, Bonde JP. Environmental factors and semen quality. Int J Occup Med Environ Health 2009; 22 (4) 305-329
    PubMedGoogle Scholar
  • 31 Oliva A, Spira A, Multigner L. Contribution of environmental factors to the risk of male infertility. Hum Reprod 2001; 16 (8) 1768-1776
    CrossrefPubMedGoogle Scholar
  • 32 Hamid Q, Hamid S, Minhas LA, Gul A. Influence of cimetidine and bromocriptine on prolactin levels in rat fertility. J Physiol Pathophysiol Pharmacol 2009; 1: 33-40
    PubMedGoogle Scholar
  • 33 França LR, Leal MC, Sasso-Cerri E, Vasconcelos A, Debeljuk L, Russell LD. Cimetidine (Tagamet) is a reproductive toxicant in male rats affecting peritubular cells. Biol Reprod 2000; 63 (5) 1403-1412
    CrossrefPubMedGoogle Scholar
  • 34 Knigge U, Dejgaard A, Wollesen F, Ingerslev O, Bennett P, Christiansen PM. The acute and long term effect of the H2-receptor antagonists cimetidine and ranitidine on the pituitary-gonadal axis in men. Clin Endocrinol (Oxf) 1983; 18 (3) 307-313
    CrossrefPubMedGoogle Scholar
  • 35 Morakinyo AO, Iranloye BO, Daramola AO, Adegoke OA. Antifertility effect of calcium channel blockers on male rats: association with oxidative stress. Adv Med Sci 2011; 56 (1) 95-105
    PubMedGoogle Scholar
  • 36 Treviño CL, Felix R, Castellano LE , et al. Expression and differential cell distribution of low-threshold Ca(2+) channels in mammalian male germ cells and sperm. FEBS Lett 2004; 563 (1–3) 87-92
    CrossrefPubMedGoogle Scholar
  • 37 Lishko PV, Kirichok Y, Ren D, Navarro B, Chung JJ, Clapham DE. The control of male fertility by spermatozoan ion channels. Annu Rev Physiol 2012; 74: 453-475
    CrossrefPubMedGoogle Scholar
  • 38 Lee JH, Ahn HJ, Lee SJ, Gye MC, Min CK. Effects of L- and T-type Ca2(+) channel blockers on spermatogenesis and steroidogenesis in the prepubertal mouse testis. J Assist Reprod Genet 2011; 28 (1) 23-30
    CrossrefPubMedGoogle Scholar
  • 39 Stripp B, Taylor AA, Bartter FC , et al. Effect of spironolactone on sex hormones in man. J Clin Endocrinol Metab 1975; 41 (4) 777-781
    CrossrefPubMedGoogle Scholar
  • 40 Dobs AS, Miller S, Neri G , et al. Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients. Metabolism 2000; 49 (1) 115-121
    CrossrefPubMedGoogle Scholar
  • 41 Dostal LA, Juneau P, Rothwell CE. Repeated analysis of semen parameters in beagle dogs during a 2-year study with the HMG-CoA reductase inhibitor, atorvastatin. Toxicol Sci 2001; 61 (1) 128-134
    CrossrefPubMedGoogle Scholar
  • 42 Albert PS, Mininberg DT, Davis JE. The nitrofurans as sperm immobilising agents: their tissue toxicity and their clinical application. Br J Urol 1975; 47 (4) 459-462
    CrossrefPubMedGoogle Scholar
  • 43 Schlegel PN, Chang TSK, Marshall FF. Antibiotics: potential hazards to male fertility. Fertil Steril 1991; 55 (2) 235-242
    PubMedGoogle Scholar
  • 44 Guillebaud J. Sulpha-trimethoprim combinations and male infertility. Lancet 1978; 2 (8088) 523
    PubMedGoogle Scholar
  • 45 Alonso V, Linares V, Bellés M , et al. Sulfasalazine induced oxidative stress: a possible mechanism of male infertility. Reprod Toxicol 2009; 27 (1) 35-40
    CrossrefPubMedGoogle Scholar
  • 46 Fukushima T, Kato M, Adachi T , et al. Effects of sulfasalazine on sperm acrosome reaction and gene expression in the male reproductive organs of rats. Toxicol Sci 2005; 85 (1) 675-682
    CrossrefPubMedGoogle Scholar
  • 47 Feagins LA, Kane SV. Sexual and reproductive issues for men with inflammatory bowel disease. Am J Gastroenterol 2009; 104 (3) 768-773
    CrossrefPubMedGoogle Scholar
  • 48 Dejaco C, Mittermaier C, Reinisch W , et al. Azathioprine treatment and male fertility in inflammatory bowel disease. Gastroenterology 2001; 121 (5) 1048-1053
    CrossrefPubMedGoogle Scholar
  • 49 Ligumsky M, Badaan S, Lewis H, Meirow D. Effects of 6-mercaptopurine treatment on sperm production and reproductive performance: a study in male mice. Scand J Gastroenterol 2005; 40 (4) 444-449
    CrossrefPubMedGoogle Scholar
  • 50 Rajapakse RO, Korelitz BI, Zlatanic J, Baiocco PJ, Gleim GW. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol 2000; 95 (3) 684-688
    CrossrefPubMedGoogle Scholar
  • 51 Nørgård B, Pedersen L, Jacobsen J, Rasmussen SN, Sørensen HT. The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception. Aliment Pharmacol Ther 2004; 19 (6) 679-685
    CrossrefPubMedGoogle Scholar
  • 52 Mahadevan U, Terdiman JP, Aron J, Jacobsohn S, Turek P. Infliximab and semen quality in men with inflammatory bowel disease. Inflamm Bowel Dis 2005; 11 (4) 395-399
    CrossrefPubMedGoogle Scholar
  • 53 Wildi LM, Haraoui B. Reversible male infertility under treatment with an anti-TNFα agent: a case report. Ann Rheum Dis 2012; 71 (3) 473-474
    CrossrefPubMedGoogle Scholar
  • 54 Ferguson JM. The effects of antidepressants on sexual functioning in depressed patients: a review. J Clin Psychiatry 2001; 62 (Suppl. 03) 22-34
    PubMedGoogle Scholar
  • 55 Pollack MH, Reiter S, Hammerness P. Genitourinary and sexual adverse effects of psychotropic medication. Int J Psychiatry Med 1992; 22 (4) 305-327
    PubMedGoogle Scholar
  • 56 Tanrikut C, Feldman AS, Altemus M, Paduch DA, Schlegel PN. Adverse effect of paroxetine on sperm. Fertil Steril 2010; 94 (3) 1021-1026
    CrossrefPubMedGoogle Scholar
  • 57 Göçmez SS, Utkan T, Ulak G, Gacar N, Erden F. Effects of long-term treatment with fluoxetine and venlafaxine on rat isolated vas deferens. Auton Autacoid Pharmacol 2010; 30 (3) 197-202
    CrossrefPubMedGoogle Scholar
  • 58 Safarinejad MR. Sperm DNA damage and semen quality impairment after treatment with selective serotonin reuptake inhibitors detected using semen analysis and sperm chromatin structure assay. J Urol 2008; 180 (5) 2124-2128
    CrossrefPubMedGoogle Scholar
  • 59 Master VA, Turek PJ. Ejaculatory physiology and dysfunction. Urol Clin North Am 2001; 28 (2) 363-375 , x
    CrossrefPubMedGoogle Scholar
  • 60 Serretti A, Chiesa A. A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. Int Clin Psychopharmacol 2011; 26 (3) 130-140
    CrossrefPubMedGoogle Scholar
  • 61 Kenney LB, Laufer MR, Grant FD, Grier H, Diller L. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer 2001; 91 (3) 613-621
    CrossrefPubMedGoogle Scholar
  • 62 Ragheb AM, Sabanegh Jr ES. Male fertility-implications of anticancer treatment and strategies to mitigate gonadotoxicity. Anticancer Agents Med Chem 2010; 10 (1) 92-102
    CrossrefPubMedGoogle Scholar
  • 63 Brydøy M, Fosså SD, Klepp O , et al; Norwegian Urology Cancer Group III study group. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy. Eur Urol 2010; 58 (1) 134-140
    CrossrefPubMedGoogle Scholar
  • 64 Brydøy M, Fosså SD, Klepp O , et al. Paternity following treatment for testicular cancer. J Natl Cancer Inst 2005; 97 (21) 1580-1588
    CrossrefPubMedGoogle Scholar
  • 65 Fertile Hope 2012 Available at: http://www.fertilehope.org/index.cfm . Accessed March 23, 2012
    PubMed
  • 66 Chiba K, Yamaguchi K, Li F, Ando M, Fujisawa M. Finasteride-associated male infertility. Fertil Steril 2011; 95 (5) e9-e11
    PubMedGoogle Scholar
  • 67 Liu KE, Binsaleh S, Lo KC, Jarvi K. Propecia-induced spermatogenic failure: a report of two cases. Fertil Steril 2008; 90 (3) e17-e19
    PubMedGoogle Scholar
  • 68 Tu HYV, Zini A. Finasteride-induced secondary infertility associated with sperm DNA damage. Fertil Steril 2011; 95 (6) e13-e14
    CrossrefPubMedGoogle Scholar
  • 69 Amory JK, Wang C, Swerdloff RS , et al. The effect of 5 alpha reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men. J Clin Endo Met 2007; 92: 1659
    CrossrefPubMedGoogle Scholar
  • 70 Dimitriadis F, Giannakis D, Pardalidis N , et al. Effects of phosphodiesterase-5 inhibitors on sperm parameters and fertilizing capacity. Asian J Androl 2008; 10 (1) 115-133
    CrossrefPubMedGoogle Scholar
  • 71 Glenn DRJ, McVicar CM, McClure N, Lewis SE. Sildenafil citrate improves sperm motility but causes a premature acrosome reaction in vitro. Fertil Steril 2007; 87 (5) 1064-1070
    CrossrefPubMedGoogle Scholar
  • 72 Pomara G, Morelli G, Canale D , et al. Alterations in sperm motility after acute oral administration of sildenafil or tadalafil in young, infertile men. Fertil Steril 2007; 88 (4) 860-865
    CrossrefPubMedGoogle Scholar
  • 73 Hellstrom WJG, Sikka SC. Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers. J Urol 2006; 176 (4, Pt 1) 1529-1533
    CrossrefPubMedGoogle Scholar
  • 74 Hellstrom WJG, Sikka SC. Effects of alfuzosin and tamsulosin on sperm parameters in healthy men: results of a short-term, randomized, double-blind, placebo-controlled, crossover study. J Androl 2009; 30 (4) 469-474
    CrossrefPubMedGoogle Scholar